Abstract
Two important worldwide needs must be satisfied in the future; (1) treatment of the deteriorating health of an aging population and, (2) decreasing healthcare costs to meet the needs of an increased population. The ethical and economic dilemma is how to achieve equality in quality of care while at the same time decreasing cost of care for an ever-expanding number of people. The limited lifetime of prosthetic devices made from first-generation nearly inert biomaterials requires new approaches to meet these two large needs. This paper advises an expanded emphasis on: (1) regeneration of tissues and (2) prevention of tissue deterioration to meet this growing need. Innovative use of bioactive ceramics with genetic control of in situ tissue responses offers the potential to achieve both tissue regeneration and prevention. Clinical success of use of bioactive glass for bone regeneration is evidence that this concept works. Likewise the use of micron sized bioactive glass powders in a dentifrice for re-mineralization of teeth provides evidence that prevention of tissue deterioration is also possible. This opinion paper outlines clinical needs that could be met by innovative use of bioactive glasses and ceramics in the near future; including: regeneration of skeletal tissues that is patient specific and genetic based, load-bearing bioactive glass–ceramics for skeletal and ligament and tendon repair, repair and regeneration of soft tissues, and rapid low-cost analysis of human cell-biomaterial interactions leading to patient specific diagnoses and treatments using molecularly tailored bioceramics.
Similar content being viewed by others
References
Hench LL, Splinter RJ, Allen WC, Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res Symp. 1971;2(1):117–41.
Beckham CA, Greenlee TK, Crebo AR. Bone formation at a ceramic implant interface. Calcif Tissue Res. 1971;8(2):165–71.
Hench LL, Paschall HA. Direct chemical bonding of bioactive glass-ceramic materials and bone. J Biomed Mats Res Symp. 1973;4:25–42.
Piotrowski G, Hench LL, Allen WC, Miller GJ. Mechanical studies of bone bioglass interfacial bond. J Biomed Mater Res. 1975;9(4):47–61.
Clark AE, Hench LL, Paschall HA. Influence of surface chemistry on implant interface histology—theoretical basis for implant materials selection. J Biomed Mater Res. 1976;10(2):161–74.
Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res. 1981;15(6):805–17.
Hench LL, Wilson J, Greenspan D. Bioglass: a short history and bibliography. J Aust Ceram Soc. 2004;40:1–42.
Hench LL. Bioceramics—from Concept to Clinic. J Am Ceram Soc. 1991;74(7):1487–510.
Hench LL. Bioceramics. J Am Ceram Soc. 1998;81(7):1705–28.
Hench LL. An introduction to bioceramics. 2nd ed. London: Imperial College Press; 2013.
Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013;9(1):4457–86.
Wilson J, Low SB. Bioactive ceramics for periodontal treatment—comparative-studies in the patus monkey. J Appl Biomater. 1992;3(2):123–9.
Xynos ID, Hukkanen MVJ, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int. 2000;67(4):321–9.
Hench LL, Polak JM, Xynos ID, Buttery LDK. Bioactive materials to control cell cycle. Mater Res Innov. 2000;3(6):313–23.
Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun. 2000;276(2):461–5.
Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass (R) 45S5 dissolution. J Biomed Mater Res. 2001;55(2):151–7.
Hench LL, Polak JM. Third-generation biomedical materials. Science. 2002;295(5557):1014–7.
Hench LL, Xynos ID, Edgar AJ, Buttery LDK, Polak JM, Zhong JP, Liu XY, Chang J. Gene activating glasses. J Inorg Mater. 2002;17(5):897–909.
Hoppe A, Gueldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials. 2011;32(11):2757–74.
Kokubo T, Ito S, Sakka S, Yamamuro T. Formation of a high-strength bioactive glass ceramic in the system MgO–CaO–SiO2–P2O5. J Mater Sci. 1986;21(2):536–40.
Peitl O, Zanotto ED, Serbena FC, Hench LL. Compositional and microstructural design of highly bioactive P2O5–Na2O-CaO-SiO2 glass-ceramics. Acta Biomater. 2012;8(1):321–32.
Mahony O, Tsigkou O, Ionescu C, Minelli C, Ling L, Hanly R, Smith ME, Stevens MM, Jones JR. Silica-gelatin hybrids with tailorable degradation and mechanical properties for tissue regeneration. Adv Funct Mater. 2010;20(22):3835–45.
Tsigkou O, Pomerantseva I, Spencer JA, Redondo PA, Hart AR, O’Doherty E, Lin Y, Friedrich CC, Daheron L, Lin CP, Sundback CA, Vacanti JP, Neville C. Engineered vascularized bone grafts. PNAS. 2010;107(8):3311–6.
Jung SB. Bioactive borate glasses. In: Jones JR, Clare AG, editors. Bio-glasses: an introduction. Chichester: Wiley; 2012. p. 75–96.
Gillette RL, Swaim SF, Sartin EA, Bradley DM, Coolman SL. Effects of a bioactive glass on healing of closed skin wounds in dogs. Am J Vet Res. 2001;62(7):1149–53.
Hu GF, Xiao LW, Tong PJ, Bi DW, Wang H, Ma HT, Zhu G, Liu H. Antibacterial hemostatic dressings with nanoporous bioglass containing silver. Int J Nanomed. 2012;7:2613–20.
Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng. 2005;11(5–6):768–77.
Gorustovich AA, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B. 2010;16(2):199–207.
Leu A, Leach JK. Proangiogenic potential of a collagen/bioactive glass substrate. Pharm Res. 2008;25(5):1222–9.
Miguez-Pacheco V, Hench LL, Boccaccini AR. Bioactive glasses beyond bone and teeth: emerging applications in contact with soft tissues. Acta Biomater. 2015;13:1–15. doi:10.1016/j.actbio.2014.11.004.
Hench LL, Greenspan D. Interactions between bioactive glass and collagen: a review and new perspectives. J Aust Ceram Soc. 2013;49(2):1–40.
Notingher I, Bisson I, Bishop AE, Randle WL, Polak JMP, Hench LL. In situ spectral monitoring of mRNA translation in embryonic stem cells during differentiation in vitro. Anal Chem. 2004;76(11):3185–93.
Notingher L, Bisson I, Polak JM, Hench LL. In situ spectroscopic study of nucleic acids in differentiating embryonic stem cells. Vib Spectrosc. 2004;35(1–2):199–203.
Notingher I, Jell G, Notingher PL, Bisson I, Tsigkou O, Polak JM, Stevens MM, Hench LL. Multivariate analysis of Raman spectra for in vitro non-invasive studies of living cells. J Mol Struct. 2005;744:179–85.
Gentleman E, Swain RJ, Evans ND, Boonrungsiman S, Jell G, Ball MD, Shean TAV, Oyen ML, Porter A, Stevens MM. Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater. 2009;8(9):763–70.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hench, L.L. The future of bioactive ceramics. J Mater Sci: Mater Med 26, 86 (2015). https://doi.org/10.1007/s10856-015-5425-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-015-5425-3